Axsome Therapeutics reported a gross margin of 93.79% and a net margin of -23.50% for the quarter ended Jun 2026. These financial ratios cover 43 quarters of results from Dec 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 88.85% | 88.58% | 90.60% | 92.01% | 90.15% | 88.70% | 89.69% | 91.60% | 90.76% | 91.95% | -2,002.80% | 91.94% | 91.04% | 93.03% | 93.71% | 92.30% | 93.79% | ||||||||||||||||||||||||||
| EBT Margin | -469.82% | -266.08% | -251.29% | -9.13% | -145.15% | -108.80% | -138.37% | -91.14% | -91.03% | -61.67% | -14,965.40% | -48.91% | -32.61% | -27.62% | -14.35% | -33.76% | -23.44% | ||||||||||||||||||||||||||
| EBIT Margin | -444.23% | -251.76% | -245.86% | -6.74% | -139.31% | -107.49% | -137.39% | -89.70% | -89.54% | -59.78% | -14,523.40% | -46.91% | -24.47% | -26.97% | -13.75% | -33.14% | -22.73% | ||||||||||||||||||||||||||
| EBITDA Margin | -444.23% | -251.76% | -245.86% | -6.74% | -139.31% | -107.49% | -137.39% | -89.70% | -89.54% | -59.78% | -14,523.40% | -46.91% | -24.47% | -26.97% | -13.75% | -33.14% | -22.73% | ||||||||||||||||||||||||||
| Operating Margin | -444.23% | -251.76% | -245.86% | -6.74% | -139.31% | -107.49% | -137.39% | -89.70% | -89.54% | -59.78% | -14,523.40% | -46.91% | -24.47% | -26.97% | -13.75% | -33.14% | -22.73% | ||||||||||||||||||||||||||
| Net Margin | -469.82% | -266.08% | -251.29% | -11.88% | -143.83% | -107.58% | -137.89% | -91.14% | -91.03% | -61.67% | -14,982.40% | -48.91% | -31.95% | -27.62% | 4.77% | -33.76% | -23.50% | ||||||||||||||||||||||||||
| FCF Margin | -382.97% | -135.49% | -113.84% | -6.23% | -118.81% | -93.30% | -42.46% | -71.42% | -34.60% | -17.87% | -5,246.40% | -35.99% | -21.62% | 0.58% | -9.55% | -10.89% | -15.30% | ||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.02B | 0.02B | 0.01B | 0.01B | 0.02B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | |||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 0.13B | 0.10B | 0.09B | 0.13B | 0.26B | 0.34B | 0.36B | 0.50B | 0.61B | 0.59B | 0.57B | 0.55B | 0.55B | 0.56B | 0.58B | 0.62B | 0.65B | 0.68B | 0.70B | 0.74B | |||||||||||||||||||||||
| Invested CapitalInvested Cap. | 0.09B | 0.06B | 0.06B | 0.11B | 0.26B | 0.21B | 0.27B | 0.46B | 0.45B | 0.38B | 0.33B | 0.29B | 0.28B | 0.25B | 0.24B | 0.26B | 0.26B | 0.28B | 0.24B | 0.27B | |||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.10 | 0.15 | 0.40 | 0.36 | 0.37 | 0.46 | 0.44 | 0.53 | 0.61 | 0.47 | 0.54 | 0.61 | 0.68 | 0.94 | 1.01 | 1.05 | |||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.42 | 0.56 | 0.56 | 0.55 | 0.30 | 0.30 | 0.39 | 0.30 | 0.31 | 0.31 | 0.34 | 0.34 | 0.34 | 0.33 | 0.32 | 0.29 | 0.28 | 0.27 | 0.26 | 0.25 | |||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -35.61 | -42.05 | -40.61 | -36.89 | -43.23 | -54.78 | -239.02 | -49.99 | -53.19 | -38.21 | -55.41 | -48.50 | -67.38 | -54.97 | -96.61 | -108.49 | -129.37 | 993.93 | -134.66 | -249.47 | |||||||||||||||||||||||
| Price to SalesP/S | 173.32 | 115.02 | 137.67 | 28.40 | 71.90 | 57.22 | 52.69 | 50.50 | 44.15 | 41.55 | 0.00B | 47.26 | 34.66 | 35.73 | 47.41 | 45.45 | 58.62 | ||||||||||||||||||||||||||
| Price to BookP/B | 29.08 | 91.40 | 109.50 | 100.58 | 12.31 | 30.62 | 24.02 | 12.04 | 12.27 | 19.73 | 26.30 | 37.41 | 46.86 | 72.22 | 107.89 | 71.16 | 82.87 | 105.25 | 159.22 | 153.67 | |||||||||||||||||||||||
| Enterprise Value | 1.13B | 1.34B | 1.52B | 1.46B | 1.71B | 3.15B | 2.44B | 2.92B | 2.89B | 3.38B | 3.46B | 3.53B | 4.03B | 3.80B | 5.44B | 4.90B | 5.78B | 8.97B | 8.39B | 12.48B | |||||||||||||||||||||||
| EV to EBIT | -33.75 | -41.16 | -39.82 | -37.14 | -40.32 | -52.64 | -382.74 | -44.89 | -46.53 | -34.42 | -51.37 | -45.26 | -64.28 | -52.36 | -95.46 | -133.39 | -125.45 | -332.76 | -132.36 | -251.41 | |||||||||||||||||||||||
| EV to EBITDA | -33.75 | -41.16 | -39.82 | -37.14 | -40.32 | -52.64 | -382.74 | -44.89 | -46.53 | -34.42 | -51.37 | -45.26 | -64.28 | -52.36 | -95.46 | -133.39 | -125.45 | -332.76 | -132.36 | -251.41 | |||||||||||||||||||||||
| Market Capitalization | 1.24B | 1.43B | 1.61B | 1.53B | 1.94B | 3.36B | 2.69B | 3.36B | 3.31B | 3.77B | 3.79B | 3.85B | 4.35B | 4.12B | 5.74B | 5.20B | 6.11B | 9.29B | 8.69B | 12.80B | |||||||||||||||||||||||
| Price to FCFP/FCF | -45.95 | -49.54 | -48.97 | -45.26 | -84.90 | -120.93 | -455.88 | -60.52 | -61.33 | -124.10 | -70.71 | -127.58 | -232.52 | -156.97 | -131.31 | -160.32 | 0.00B | -496.33 | -417.42 | -383.25 | |||||||||||||||||||||||
| EV to FCF | -41.71 | -46.54 | -46.39 | -43.08 | -74.93 | -113.69 | -414.05 | -52.64 | -53.61 | -111.38 | -64.52 | -117.11 | -215.03 | -144.95 | -124.43 | -150.98 | 0.00B | -479.08 | -402.77 | -373.68 | |||||||||||||||||||||||
| EV to CFO | -42.11 | -46.54 | -46.69 | -43.39 | -75.14 | -114.44 | -419.10 | -52.77 | -53.98 | -111.41 | -64.64 | -117.31 | -216.07 | -145.12 | -125.40 | -151.04 | 0.00B | -480.90 | -405.12 | -378.78 | |||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -444.23% | -251.76% | -245.86% | -6.74% | -139.31% | -107.49% | -137.39% | -89.70% | -89.54% | -59.78% | -14,523.40% | -46.91% | -24.47% | -26.97% | -13.75% | -33.14% | -22.73% | ||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -113.89% | -157.60% | -212.43% | -155.98% | -76.45% | -75.34% | -56.95% | -45.08% | -39.36% | -50.87% | -69.21% | -84.82% | -85.38% | -83.78% | -79.80% | -82.91% | -72.20% | -55.46% | -65.96% | -67.15% | |||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | -48.18% | -42.49% | -56.14% | -82.63% | -98.55% | -107.28% | -106.50% | -110.53% | -90.55% | -81.07% | -49.06% | -53.18% | -58.28% | ||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -96.70% | -127.61% | -159.66% | -111.42% | -61.55% | -55.82% | -44.05% | -36.86% | -33.29% | -40.24% | -52.27% | -56.40% | -56.04% | -50.84% | -47.77% | -39.93% | -35.06% | -21.37% | -21.43% | -20.84% |